110 related articles for article (PubMed ID: 2760927)
1. Crystallization of human leukocyte elastase with its inhibitor Pro44-eglin c.
Heinz DW; Liersch M; Grütter MG
J Mol Biol; 1989 Jun; 207(3):641-2. PubMed ID: 2760927
[TBL] [Abstract][Full Text] [Related]
2. Kinetic studies on the interaction of eglin c with human leukocyte elastase and cathepsin G.
Braun NJ; Bodmer JL; Virca GD; Metz-Virca G; Maschler R; Bieth JG; Schnebli HP
Biol Chem Hoppe Seyler; 1987 Apr; 368(4):299-308. PubMed ID: 3649242
[TBL] [Abstract][Full Text] [Related]
3. Crystallization of a complex between an elastase-specific inhibitor elafin and porcine pancreatic elastase.
Tsunemi M; Matsuura Y; Sakakibara S; Katsube Y
J Mol Biol; 1993 Jul; 232(1):310-1. PubMed ID: 8331669
[TBL] [Abstract][Full Text] [Related]
4. Kinetics of the inhibition of human pancreatic elastase by recombinant eglin c. Influence of elastin.
Faller B; Dirrig S; Rabaud M; Bieth JG
Biochem J; 1990 Sep; 270(3):639-44. PubMed ID: 1700695
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of human, ovine, and baboon neutrophil elastase with Eglin c and secretory leukocyte proteinase inhibitor.
Junger WG; Hallström S; Redl H; Schlag G
Biol Chem Hoppe Seyler; 1992 Mar; 373(3):119-22. PubMed ID: 1350199
[TBL] [Abstract][Full Text] [Related]
6. Preliminary crystallographic data on the complex of bovine alpha-chymotrypsin with the recombinant proteinase inhibitor eglin c from Hirudo medicinalis.
Pugliese L; Gatti G; Bolognesi M; Coda A; Menegatti E; Schnebli HP; Ascenzi P; Amiconi G
J Mol Biol; 1989 Aug; 208(3):511-3. PubMed ID: 2795659
[TBL] [Abstract][Full Text] [Related]
7. Kinetics of the inhibition of human leucocyte elastase by eglin from the leech Hirudo medicinalis.
Baici A; Seemüller U
Biochem J; 1984 Mar; 218(3):829-33. PubMed ID: 6562888
[TBL] [Abstract][Full Text] [Related]
8. Amino acids and peptides. XXVIII. Synthesis of peptide fragments related to eglin c and studies on the relationship between their structure and effects on human leukocyte elastase, cathepsin G and alpha-chymotrypsin.
Tsuboi S; Nakabayashi K; Matsumoto Y; Teno N; Tsuda Y; Okada Y; Nagamatsu Y; Yamamoto J
Chem Pharm Bull (Tokyo); 1990 Sep; 38(9):2369-76. PubMed ID: 2285973
[TBL] [Abstract][Full Text] [Related]
9. Crystallization and preliminary diffraction studies of porcine pancreatic elastase in complex with a novel inhibitor.
Oliveira TF; Mulchande J; Moreira R; Iley J; Archer M
Protein Pept Lett; 2007; 14(1):93-5. PubMed ID: 17266656
[TBL] [Abstract][Full Text] [Related]
10. X-ray crystal structure of the serine proteinase inhibitor eglin c at 1.95 A resolution.
Hipler K; Priestle JP; Rahuel J; Grütter MG
FEBS Lett; 1992 Sep; 309(2):139-45. PubMed ID: 1505678
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of peptide fragments related to eglin c and examination of their inhibitory effect on human leukocyte elastase, cathepsin G and alpha-chymotrypsin.
Okada Y; Tsuboi S; Tsuda Y; Nakabayashi K; Nagamatsu Y; Yamamoto J
Biochem Biophys Res Commun; 1989 May; 161(1):272-5. PubMed ID: 2730658
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of a trihexacontapeptide corresponding to the sequence 8-70 of eglin c and studies on the relationship between the structure and the inhibitory activity against human leukocyte elastase, cathepsin G and alpha-chymotrypsin.
Okada Y; Tsuboi S; Tsuda Y; Nagamatsu Y; Yamamoto J
FEBS Lett; 1990 Oct; 272(1-2):113-6. PubMed ID: 2226822
[TBL] [Abstract][Full Text] [Related]
13. Conductimetry: a new tool for studying inhibition of elastolysis.
Saulnier J; Bostancioglu K; Favre-Bonvin G; Wallach J
Biol Chem Hoppe Seyler; 1988 May; 369 Suppl():75-8. PubMed ID: 3202974
[TBL] [Abstract][Full Text] [Related]
14. Biochemical properties and possible therapeutic role of the elastase inhibitor eglin C.
Schnebli HP; Seemüller U; Fritz H; Maschler R; Liersch M; Bodmer JL; Virca GD; Lucey EC; Stone PG; Snider GL
Prog Clin Biol Res; 1985; 180():287-90. PubMed ID: 3849804
[No Abstract] [Full Text] [Related]
15. Human plasminogen kringle 4. Crystallization and preliminary diffraction data of two different crystal forms.
Mulichak AM; Park CH; Tulinsky A; Petros AM; Llinás M
J Biol Chem; 1989 Feb; 264(4):1922-3. PubMed ID: 2914886
[TBL] [Abstract][Full Text] [Related]
16. Crystallization and preliminary x-ray analysis of complexes of porcine pancreatic elastase with two natural inhibitors.
Hilpert K; Wessner H; Scholz C; Scheerer P; Volkmer-Engert R; Kraubeta N
Protein Pept Lett; 2004 Aug; 11(4):393-9. PubMed ID: 15327373
[TBL] [Abstract][Full Text] [Related]
17. Amino acids and peptides. XXX. Synthesis of eglin c (41-49) and eglin c (60-63) and examination of their inhibitory activity towards human leukocyte elastase, cathepsin G, porcine pancreatic elastase and alpha-chymotrypsin.
Tsuboi S; Takeda M; Okada Y; Nagamatsu Y; Yamamoto J
Chem Pharm Bull (Tokyo); 1991 Jan; 39(1):184-6. PubMed ID: 2049802
[TBL] [Abstract][Full Text] [Related]
18. Refined crystal structures of subtilisin novo in complex with wild-type and two mutant eglins. Comparison with other serine proteinase inhibitor complexes.
Heinz DW; Priestle JP; Rahuel J; Wilson KS; Grütter MG
J Mol Biol; 1991 Jan; 217(2):353-71. PubMed ID: 1992167
[TBL] [Abstract][Full Text] [Related]
19. Crystallization and preliminary X-ray analysis of the complex of porcine pancreatic elastase and a hybrid squash inhibitor.
Hilpert K; Schneider-Mergener J; Aÿ J
Acta Crystallogr D Biol Crystallogr; 2002 Apr; 58(Pt 4):672-4. PubMed ID: 11914493
[TBL] [Abstract][Full Text] [Related]
20. Isolation and characterization of porcine leukocyte elastase. Leukocyte elastase-inhibitor complexes in porcine blood, II.
Geiger R; Junk A; Jochum M
J Clin Chem Clin Biochem; 1985 Dec; 23(12):821-8. PubMed ID: 3854325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
